OpenAI's rebrand balances the technical and the emotional by updating its logo and centering a new typeface called OpenAI ...

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The ...

Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

While some information has been restored, scientists are still alarmed over the removal of data. It's not clear what has ...

Onc.AI presented results at the Society for Immunotherapy of Cancer (SITC), showcasing a multi-institutional study demonstrating that Serial CTRS improved the prediction of overall survival for ...

The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic diseases, which is driving the need for biologics development ...

The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...

Noga Barpal from PxE Imaging and Linda Reschke from Basler discuss how AI and 3D imaging are transforming industrial vision in this Visionaries webcast.